Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia

Medical and Pediatric Oncology

Volumn 41, Issue 2, 2003, Pages 110-114

  Petersen, Kamilla B ^a   Müller, Jørn ^b   Rasmussen, Mette ^a   Schmiegelow, Kjeld ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Acute lymphoblastic leukemia; Childhood leukemia; Glucocorticoids; Pituitary adrenal system

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADRENAL DISEASE; ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; ARTICLE; CANCER PATIENT; CANCER REGRESSION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CORTICOTROPIN TEST; FOLLOW UP; HUMAN; PRIORITY JOURNAL; SUBSTITUTION THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL GLANDS; ADRENAL INSUFFICIENCY; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PREDNISOLONE;

EID: 0038714754     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10316     Document Type: Article

References (29)

1. Gaynon PS, Lustig RH. The use of glucocorticoids in acute lymphoblastic leukemia of childhood. J Pediatr Hematol Oncol 1995;17:1-12.
2. Gustafsson G, Schmiegelow K, Forestier E, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 2000;14:2267-2275.
3. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 9th edition. New York: McGraw-Hill; 1996. pp 1459-1485.
4. Attard-Montalto SP, Camacho-Hübner C, Cotterill AM, et al. Changes in protein turnover, IGF-I and IGF binding proteins in children with cancer. Acta Pædiatr 1998;87:54-60.
5. Levine A, Cohen D, Zadik Z. Urinary free cortisol values in children under stress. J Pediatr 1994;125:853-857.
6. Nickels D, Moore DC. Serum cortisol responses in febrile children. Pediatr Infect Dis 1989;8:16-19.
7. Zurbrügg RP, Zimmermann E, Oetliker OH. Adrenocortical function following long-term corticosteroid treatment. Helv Paediatr Acta 1974;29:221-235.
8. Morris HG, Jorgensen JR. Recovery of endogenous pituitary-adrenal function in corticosteroid-treated children. J Pediatr 1971;79:480-486.
9. Oberger E, Thorén M, Engström I. Long-term treatment with corticosteroid/ACTH in asthmatic children. Acta Pædiatr Scand 1986;75:164-171.
10. Henzen C, Suter A, Lerch E, et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000;355:542-545.
11. Schlaghecke R, Kornely E, Santen R, et al. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 1992;326:226-230.
12. Spiegel RJ, Oliff AI, Bruton J, et al. Adrenal suppression after short-term corticosteroid therapy. Lancet 1979;1:630-633.
13. Lightner ES, Johnson H, Corrigan JJ. Rapid adrenocortical recovery after short-term glucocorticoid therapy. Am J Dis Child 1981;135:790-792.
14. Felner EI, Thompson MT, Ratliff AF, et al. Time course of recovery of adrenal function in children treated for leukemia. J Pediatr 2000;137:21-24.
15. Kuperman H, Damiani D, Chrousos GP, et al. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy. J Clin Endocrinol Metab 2001;86:2993-2996.
16. Albano EA, Pizzo PA. Infectious complications in childhood acute leukemias. Pediatr Clin North Am 1988;35:873-901.
17. Wheeler K, Chessells JM, Bailey CC, et al. Treatment related deaths during induction and in first remission in acute lymphoblastic leukemia: MRC UKALL X. Arch Dis Child 1996;74:101-107.
18. Abdu TAM, Elhadd TA, Neary R, et al. Comparison of the low dose short synacthen test (1 μg), the conventional dose short synacthen test (250 μg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999;84:838-843.
19. Lindholm J, Kehlet H. Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function. Clin Endocrinol 1987;26:53-59.
20. Rasmuson S, Olsson T, Hägg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996;44:151-156.
21. Zora JA, Zimmerman D, Carey TL, et al. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 1986;77:9-13.
22. Streck WF, Lockwood DH. Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med 1979;66:910-914.
23. Albert SG, DeLeon MJ, Silverberg AB. Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients. Crit Care Med 2001;29:668-670.
24. Shibata S, Kami M, Kanda Y, et al. Acute adrenal failure associated with fluconazole after administration of high-dose cyclophosphamide. Am J Hematol 2001;66:303-305.
25. Michaelis G, Zeiler D, Biscoping J, et al. Function of the adrenal cortex during therapy with fluconazole in intensive care patients. Mycoses 1993;36:117-123.
26. Lazar JD, Wilner KD. Drug interactions with fluconazole. Rev Infect Dis 1990;12:S327-S333.
27. Stewart PM, Seckl JR, Corrie J, et al. A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet 1988;1:1208-1210.
28. May ME, Carey RM. Rapid adrenocorticotropic hormone test in practice. Am J Med 1985;79:679-684.
29. Jusko WJ. Corticosteroid pharmacodynamics: Models for a broad array of receptor-mediated pharmacologic effects. J Clin Pharmacol 1990;30:303-310.